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Abstract
Purpose We recently reported evidence suggesting associ-
ations between urine cadmium concentrations, reflecting
long-term exposure, measured in 25 female patients (relative
risk=1.41, P=0.412) and 15 of their male partners (relative
risk=0.19, P=0.097) and oocyte fertilization in vitro. Blood
cadmium concentrations reflect more recent exposure.
Methods We here incorporate those measures into our prior
data set and employ multivariable log-binomial regression
models to generate hypotheses concerning the relative
effects of long-term and recent cadmium exposure on
oocyte fertilization in vitro.
Results No association is indicated for blood cadmium
from women and oocyte fertilization, adjusted for urine
cadmium and creatinine, blood lead and mercury, age, race/
ethnicity and cigarette smoking (relative risk=0.88, P=
0.828). However, we suggest an inverse adjusted associa-
tion between blood cadmium from men and oocyte
fertilization (relative risk=0.66, P=0.143).
Conclusions These results suggest that consideration of
long-term and recent exposures are both important for
assessing the effect of partner cadmium levels on oocyte
fertilization in vitro.
Keywords Cadmium (Cd).Oocyte fertilization.
In vitro fertilization (IVF).Assisted reproductive
technologies (ART)
Introduction
We recently reported data suggesting associations between
long-term cadmium (Cd) exposure and oocyte fertilization
during in-vitro fertilization (IVF) treatment [1]. These
results indicated the possibility of a positive association
between concentrations of urine Cd and oocyte fertilization
in female IVF patients (adjusted relative risk (aRR)=1.41).
These prior results also suggest the possibility of an inverse
association between urine Cd in male partners of IVF
patients and oocyte fertilization (aRR=0.19).
Capsule Adjusted for long-term exposure, recent cadmium (Cd)
exposure among the male partners of female in vitro fertilization
patients may be inversely associated with oocyte fertilization.
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DOI 10.1007/s10815-010-9437-0Urine Cd is generally recognized as a marker of long-
term exposure, reflecting deposition in the kidney over
time, and likely resulting from dietary sources in our study
population. In this study, we expand our previous data set to
incorporate blood Cd concentrations which reflect recent
exposure, on the order of days to weeks [2]. Following
exposure, a small proportion of Cd concentrates in the blood,
primarily bound to erythrocytes, as well as to plasma
albumin and metallothionein and reflects exposure during
the preceding 2–3m o n t h s[ 3]. The aim of this preliminary
study is to generate hypotheses concerning the relative
contribution, if any, of recent Cd exposure to the effects
suggested for long-term Cd exposure in our prior study.
Methods
Fifty-eight female patients and 36 male partners undergoing
IVF treatment at the UCSF Center for Reproductive Health
were recruited to the Study of Metals and Assisted
Reproductive Technologies (SMART) between September
1st, 2007 and August 31st, 2008. Sample selection and
clinical protocols were previously described in detail [1].
Female patients underwent gonadotropin-induced ovarian
stimulation per clinic protocols. When at least two follicles
exceeded 17 mm in diameter, human chorionic gonadotro-
pin was administered and oocytes were retrieved 36 h later.
Between two and 39 mature oocytes were collected from
each woman. Collected oocytes were fertilized by conven-
tional insemination or by intracytoplasmic sperm injection
using sperm from male partners or a donor. Approximately
16–18 h following insemination, zygotes were identified by
the appearance of two pronuclei. A single whole blood and
a single urine specimen were obtained concurrently from
each female patient at the time of oocyte retrieval, and from
each male partner, when available, on the same day. Blood
specimens were obtained from 50 female patients and 33
male partners. Informed consent was obtained from all
study participants and the study protocol was approved by
the Institutional Review Board of the University of
California at San Francisco.
Blood and urine specimens were analyzed for Cd using
methods validated for a Perkin Elmer Sciex ELAN DRC II
inductively coupled plasma-mass spectrometer (Perki-
nElmer Life and Analytical Sciences, Shelton, CT) with
dynamic reaction cell (DRC-ICP-MS) technology. For each
study participant, 1.8 mL cryovials, containing whole blood
or urine, were shipped on dry ice to the Wadsworth
Center’s Laboratory of Inorganic and Nuclear Chemistry
at the New York State (NYS) Department of Health
(Albany, NY) for analysis. The Wadsworth Center is
certified under NYS, CLIA and OSHA regulations and
successfully participates in proficiency testing (PT) pro-
grams for blood and urine Cd operated by the NYS
Department of Health, the Institut National de Santé
Publique du Québec, Le Centre de Toxicologie du Québec,
the University of Surrey, UK, as well as in the German
External Quality Assessment Scheme, operated by the
Institute and Outpatient Clinic for Occupational, Social
and Environmental Medicine of the Friedrich-Alexander
University, Erlangen-Nuremberg, Germany.
The analytic procedure has been previously described in
detail [4] as have the details for the urine Cd, blood hg and
blood Pb analyses [1]. The analyses were carried out under
Class 100 Clean Room conditions. A minimum of six Cd
standards traceable to the National Institute of Standards
and Technology (NIST) were used for calibration. Blood
and urine specimens were analyzed for Cd by monitoring
m/z=114. Four blood or urine levels of internal quality
control (QC) materials were analyzed during each run.
Typical coefficients of variation for these assays range from
3% to 6% for blood Cd and 1% to 3% for urine Cd. Method
accuracy is periodically assessed by analyzing NIST
Standard Reference Material 966 (Toxic Metals in Bovine
Blood), and NIST SRM 2670a (Toxic Elements in Urine).
Method performance for blood and urine Cd is also
assessed via participation in the four external quality
assessment schemes previously mentioned. The limit of
detection (LOD), defined as three times the standard
deviation of concentrations measured in matrix blanks for
10independentanalyses,is0.2μg/Lforbloodand0.02μg/L
for urine. Values were reported forresearch purposeswithout
regard for the LOD to preclude the introduction of bias into
statistical models [5].
Statistical significance was defined as P<0.10 for a two-
tailed test consistent with the hypothesis generation nature
of this study. Non-parametric tests were employed to assess
bivariate associations due to lack of normality. Multiple
log-binomial regression was used to assess associations
between oocyte fertilization (no/yes) and the concentrations
of blood and urine Cd with adjustment for urine creatinine,
blood Hg, blood Pb, age, race/ethnicity and cigarette
smoking. These covariates were selected a priori for
inclusion in multiple log-binomial regression models using
literature review followed by incorporation into directed
acyclic graphs (DAGs). Directed acyclic graphs employ
causal graphing theory to identify a minimally sufficient set
of variables with which to control confounding under a
postulated causal pathway [6]. Clinical variables, including
semen quality, ICSI vs. conventional insemination, and
other treatment related factors represent intermediate
variables in the causal pathway between exposure (i.e.,
metals concentrations) and endpoint (i.e., oocyte fertiliza-
tions). Thus, these variables were excluded from multivar-
iable analysis to preclude the introduction of bias that
would result from their incorporation [7]. Generalized
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standard errors. The Quasi-likelihood information criterion
(QIC) was used to assess model fit given the non-likelihood
based nature of GEE; a smaller QIC value indicates
improved model fit [8]. SAS v.9.2 (SAS Institute, Cary,
NC) was used for all statistical analyses.
Results
Table 1 shows the distribution of blood Cd concentrations
measured on the day of oocyte collection in female patients
and their male partners; 68% and 42.4% of female and male
values were above the LOD respectively. Concentrations of
blood and urine Cd are correlated in female patients (r=0.47,
P=0.0008) but not in male partners (r=0.17, P=0.350). A
larger proportion of each woman’s oocytes were fertilized by
ICSI (median=0.76, n=37) than by conventional insemina-
tion (median=0.56, n=21). However, no significant differ-
ence is detected by insemination protocol for concentrations
of metals measured in women (P> 0 . 2 1 9 )o rm e n( P>0.235).
The log-binomial regression of oocyte fertilization on
urine and blood Cd measured in 25 female patients is
presented in Table 2. As reported previously, Model 1 for
female patients including urine Cd as the sole predictor of
interest suggests a 41% increase in the probability for
oocyte fertilization per µg/L increase in urine Cd. In Model
2, the addition of blood Cd concentrations to Model 1 has
little impact on the effect of urine Cd (i.e., a 5% increase in
magnitude) and does not improve model fit as indicated by
the increase in QIC value (i.e., 452.91–444.50=+8.41).
Asian race/ethnicity among female patients is a positive
predictor of oocyte fertilization in Model 2 in which blood
and urine Cd are the predictors of interest (RR=1.27, P=
0.0316), consistent with our prior report [1].
The adjusted log-binomial regression models of oocyte
fertilization on urine and blood Cd measured in 15 male
partners is also presented in Table 2.A sr e p o r t e d
previously, Model 1, including urine Cd as the only
predictor of interest, suggests an 81% decrease in the
probability for oocyte fertilization per µg/L increase in
urine Cd concentration. In Model 2, the addition of blood
Cd concentrations to Model 1 has a substantial impact on
the effect of urine Cd (i.e., 26% increase in magnitude) and
model fit is improved (i.e., 307.00–309.53=−2.53). Fur-
thermore, Model 2 suggests that a µg/L increase in blood
Cd concentrations is associated with a 34% decrease in the
probability for oocyte fertilization, conditional on urine Cd
concentrations and other covariates. Cigarette smoking
among male partners is a positive predictor of oocyte
fertilization in Model 2 in which blood and urine Cd are the
predictors of interest (RR=1.95, P<0.0001), consistent
with our prior report [1]. In contrast to this observation,
unadjusted analysis demonstrates no association between
smoking and oocyte fertilization (RR=1.04, P=0.754)
indicating that this association is confounded by the
considered covariates.
Discussion
In this study we expand our prior data set [1]b y
incorporating blood Cd concentrations and present evidence
suggesting the potential importance of recent male Cd
exposure on oocyte fertilization in vitro. The results of this
preliminary study raise the possibility of a gender specific
effect in which blood Cd concentrations in male IVF
partners, but not female patients, appear to be important.
The blood Cd concentrations measured in our samples are
similar to or less than those measured for the U.S. population
as reported by the National Health and Nutrition Examination
Survey [9]. Median (95% CI) blood Cd concentrations for
female patients and male partners are 0.27 µg/L (0.22–0.37)
and 0.18 µg/L (0.14–0.21), respectively. Median (95% CI)
blood Cd concentrations for U.S. females and males are
0.30 µg/L (<0.30 (LOD)−0.30) and 0.30 µg/L (0.30–0.40)
respectively. We previously reported a similar pattern for
urine Cd concentrations in which the median value for female
Table 1 Distribution of blood and urine cadmium concentrations measured on the day of oocyte collection in female patients and their male
partners; the Study of Metals and Assisted Reproductive Technologies (SMART)
n Mean SD Min Median Max r
a
Female patients
Blood cadmium (μg/L) 50 0.40 0.51 0.08 0.27 3.60 0.47
**
Urine cadmium (μg/g creatinine) 55 0.30 0.17 0.04 0.30 0.98
Male partners
Blood cadmium (μg/L) 33 0.23 0.19 0.05 0.18 0.97 0.17
Urine cadmium (μg/g creatinine) 36 0.15 0.11 −0.07 0.13 0.51
aCorrelation coefficients for blood cadmium and urine cadmium
Max, maximum value; Min, minimum value; SD, standard deviation
** P≤0.10
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the median value for the male partners is somewhat lower
than that reported for U.S. males [1].
Here we report a positive correlation between urine and
blood Cd concentrations in female patients (r=0.47, P=
0.0008). This result is consistent with that from the log-
binomial regression model (i.e., “Model 2”), indicating that
blood Cd and urine Cd may be markers for the same
exposure, vis a vis, blood Cd does not contribute different
information than does urine Cd. Other investigators have
previously reported similar findings (r=0.39, P<0.01) for
the correlation between blood and urine Cd in women [10].
A recent study of women undergoing IVF reported no
association between blood Cd and oocyte fertilization [11],
consistent with the results of this study.
In contrast to the results for female patients, blood and
urine Cd in males partners were not correlated (r=0.17, P=
0.350). This result underscores the improvement detected for
the fit of the log-binomial model for oocyte fertilization,
upon the inclusion of blood Cd as an additional predictor
variable (i.e., change in QIC=−2.53). Numerous studies
indicate inverse associations between blood Cd concentra-
tions and sperm quality, including count, morphology, and
motility [12, 13]. In contrast, data describing associations
between blood Cd levels and oocyte fertilization is compar-
atively sparse. Additional studies describe inverse associa-
tion between seminal Cd concentrations and human fertility
[14, 15] although we did not have these measures available.
It is tempting to speculate with regard to biologic
mechanisms that might be involved in the suggested
positive or inverse associations between oocyte fertilization
and Cd exposure in female IVF patients and Cd exposure in
male IVF partners, respectively. Several toxic metals,
including Cd
2+, enter eukaryotic cells directly [16] via
Ca
2+ channels and may directly bind to and interfere with
cytoskeletal function [17] and/or the estrogen receptor [18].
Cadmium accumulating in reproductive tissues might
directly enter cells of the cumulus-oocyte-complex [19,
20] or be delivered to the oocyte while bound to penetrating
sperm [14, 21]. Once within a cell Cd
2+ might elicit
oxidative damage directly [22], leading to mitotic failure or
cell death, or indirectly by depleting intracellular stores of
thiols and thereby limiting anti-oxidant enzyme activity
[23]. Furthermore, Cd
2+ may bind the intracellular estrogen
receptor [18, 24] in agonistic fashion and might thereby
alter the complex gonadotropin-mediated process of fertil-
ization induced meiotic resumption [25].
A penetrating sperm not only delivers the paternal
haploid genome to an oocyte but also a heretofore unknown
meiosis resumption signal and a centriole which is required
for microtubule assembly and initial zygote development
[26]. Metals bound to the cytoskeletal elements of
spermatozoa, such as Cd, might interfere with resumption
of oocyte meiosis and consequently oocyte fertilization in
ICSI and conventional insemination cases [27]. Alternately,
Cd-induced toxicity of sperm may directly account for the
inverse association suggested for male urine Cd and oocyte
fertilization in this study [14]. Unfortunately, we did not
have sperm quality/function data available for this prelim-
inary study and thus evaluation of this possibility will also
require further study. The conditionally-independent effects
suggested for recent and long-term Cd exposure among
males may reflect different biologic mechanisms associated
with the distinct exposure patterns, such as oxidative stress
and estrogen receptor binding, respectively.
To our knowledge, this preliminary study constitutes the
first report of a possible association between oocyte
fertilization in vitro and recent Cd exposure among males,
conditionally independent of the effects of long-term
exposure. Due to the limited sample size we were unable
to simultaneously evaluate exposures in women and men,
or to explore potential effect modification by insemination
Table 2 Multiple log-binomial regression models of oocyte fertilization in vitro on concentrations of urine and/or blood cadmium measured in 25
female patients and 15 male partners, with generalized estimating equations used to generate robust standard errors; the Study of Metals and
Assisted Reproductive Technologies (SMART)
Models
a Variables RR 95% CI p-value QIC
Low High
Female patients Model 1 Urine cadmium (μg/L) 1.41 0.62 3.17 0.412 444.50
Model 2 Urine cadmium (μg/L) 1.48 0.60 3.66 0.391 452.91
Blood cadmium (μg/L) 0.88 0.28 2.80 0.828
Male partners Model 1 Urine cadmium (μg/L) 0.19 0.03 1.35 0.097 309.53
Model 2 Urine cadmium (μg/L) 0.14 0.02 1.32 0.087 307.00
Blood cadmium (μg/L) 0.66 0.38 1.15 0.143
CI confidence interval, RR Relative risk for oocyte fertilization, QIC Quasi-likelihood Information Criteria
aModels include blood lead, blood mercury, age, race/ethnicity, cigarette smoking and urine creatinine (mg/dL) entered as covariates
Table 2 Multiple log-binomial regression models of oocyte fertiliza-
tion in vitro on concentrations of urine and/or blood cadmium
measured in 25 female patients and 15 male partners, with generalized
estimating equations used to generate robust standard errors; the Study
of Metals and Assisted Reproductive Technologies (SMART)
466 J Assist Reprod Genet (2010) 27:463–468protocol, a scenario in which associations between metals
and oocyte fertilization may differ in ICSI vs. conventional
insemination couples. As an intermediate variable in the
causal pathway between exposure and endpoint, insemina-
tion protocol does not confound associations between
metals and oocyte fertilization; however, differences in the
proportions of fertilized oocytes by these approaches raise
the possibility for effect modification. Furthermore, a
substantial proportion of values were below the LOD
which somewhat undermines these study results. The
results of this study can only be considered preliminary;
however, they indicate that both recent and long-term Cd
exposure should be considered when assessing the impact
of exposure on oocyte fertilization during IVF.
Conclusion
A future study, with a larger sample size will permit not
only increased statistical power but will facilitate simulta-
neous consideration of female and male exposures [28],
both long-term and recent, and oocyte fertilization during
IVF, and permit consideration of effect modification by
insemination protocol.
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